Corona virus pandemic is counted into one of the worst pandemic humans ever faced. In very short period of time it became a global pandemic and till now it has caused millions of deaths worldwide.
The worst part was that no country had an effective vaccine to treat COVID19 infection and the only effective solution to control the spread of this infection was complete nationwide lockdowns.
Lockdowns were quite effective to control the spread of coronavirus infection but at the same time, nationwide lockdowns cause major economic downfalls and unemployment.
Since the pandemic was begun many countries start their quest to develop an effective medicine and only a handful of countries has able to develop a vaccine which can cure coronavirus infection.
In India, the quest for the development of coronavirus vaccine was also started and Bharat biotech has successfully able to develop vaccine indigenously in collaboration with Indian national institute of virology.
Bharat biotech is a major pharmaceutical firm in India and has developed many other vaccines in past.
History of Bharat biotech
Bharat biotech is Hyderabad based pharmaceutical company and it was founded by Dr. Krishana M. Ella is year 1996.
Dr. Krishana returned from US and was dedicated to start a company which can produce innovative vaccines and bio-therapeutics. Over the period of time, He assembled a team of brilliant scientists and which led the creation of new innovative vaccines.
Today Bharat biotech has more than 160 patents. Bharat biotech is the firm which has the honour to develop world’s cheapest hepatitis vaccine when a particular vaccine is available at a very cheap price sometimes company falsely get accused of producing low-quality vaccines to keep the price low but the motive of the Bharat biotech was to produce affordable vaccine so that everyone can afford the vaccine.
Founder of the company said that Bharat biotech produces high-quality vaccines and cheapest price so that no citizen should be deprived of healthcare.
Achievements of Bharat Biotech
Bharat biotech in one of the largest vaccine producer of India and it has more than 160 patents.
Bharat biotech is the first company in the world to manufacture a preservative-free Hepatitis B vaccine also the company produce world’s cheapest hepatitis vaccine.
Bharat biotech was also the first pharmaceutical company in the world to discover the vaccine for Zika virus.
In 2014 the company has launched JENVAC which was an effective and safe vaccine which provide protection against all strains of Japanese encephalitis.
Bharat biotech was also the first company to develop vaccine for rotavirus and the vaccine was launched by Shri. Narendra Modi, Prime Minister of India under ”Make in India” initiative.
Bharat biotech has achieved the milestone of supplying 100 million doses of rotavirus.
The company has achieved the milestone of providing over 3 billion doses of various vaccines globally at very affordable prices.
Bharat biotech has acquired Chairon Behring from GSK in 2019 and become the largest producer of rabies shots.
Covaxin and its effectiveness
Till now only few pharmaceutical companies around the world has been able to develop vaccine to cure corona virus infection.
US pharmaceutical companies such as Pfizer and Moderna, Swedish and UK based AstraZeneca and Oxford has developed a vaccine for coronavirus.
In India Bharat Biotech has indigenously developed and produced vaccine to cure coronavirus infection.
Bharat biotech’s vaccine to cure corona virus infection is known as Covaxin. Covaxin has got the approval for emergency usage by Drugs Controller General of India (DCGI).
Covaxin needs to administer in two doses and the vaccine has to be stored in temperature between 2 – 8 degree Celsius.
Bharat Biotech has developed this vaccine in joint collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology, Pune (NIV).
While India’s indigenous vaccine has faced criticism for emergency approval also facing queries related to its efficacy and safety.
However, Bharat biotech’s MD Krishana M. Ella has assured that Covaxin is “200 per cent safe” and “Covaxin has shown less than 10 per cent adverse effects” while other vaccine to cure corona virus has shown far higher side effects.
Other vaccines were required to provide paracetamol to suppress side effects while we haven’t given paracetamol to any volunteer. I can assure you that our vaccine is 200 per cent safe” said Dr Krishana.
The vaccine was found to be safe and effective in phase 1 and 2. The phase 3 trials efficacy trials were planned to conduct in India on 25,800 volunteers.
And approximately 22,500 participants have been vaccinated across the country and the vaccine has been found safe to use as per data available till date, said by DCGI VG Somani earlier.
Replying to other critics Bharat biotech’s chairman Dr. Krishana Ella said that his firm had conducted “200 per cent honest clinical trials”.
Speaking to the media conference, Ella said that Bharat biotech is not only conducting trials in India, nut also in 12 other countries include UK and Bharat biotech has a track record of producing safe and effective vaccines.
Ella also replied to critics that Bharat biotech has conducted honest trials and he will provide confirmed data in week and by march Covaxin phase 3 efficacy data will be available.
He also said Bharat biotech has manufactured 16 vaccines and don’t accuse us of being inexperience. We are a global company which produces safe and effective vaccines.
He further added the company has already produced 20 million doses of Covaxin and aiming to achieve 700 million doses capacity in four facilities.